<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: We investigated the prevalence of <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> (MVP) and its association with <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> in a cohort with 'unexplained' out-of-hospital <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> (OHCA) </plain></SENT>
<SENT sid="1" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0004308'>Ventricular arrhythmias</z:hpo> are an important cause of sudden unexpected <z:hpo ids='HP_0011420'>death</z:hpo> (SUD) in the young </plain></SENT>
<SENT sid="2" pm="."><plain>The role of MVP in SUD remains controversial </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Of 1200 patients evaluated between 07/2000 and 12/2009 in our <z:hpo ids='HP_0001657'>Long QT Syndrome</z:hpo>/Genetic Heart Rhythm Clinic, we reviewed <z:hpo ids='HP_0000001'>all</z:hpo> 24 (16 females, median age 33.5 years) with idiopathic OHCA (i.e. <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/<z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>/<z:e sem="disease" ids="C1720983" disease_type="Disease or Syndrome" abbrv="">channelopathy</z:e> negative) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> 24 patients had implantable cardioverter defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>OHCA was the sentinel event in 22 (92%) </plain></SENT>
<SENT sid="6" pm="."><plain>Bileaflet MVP was found in 10 (42%) </plain></SENT>
<SENT sid="7" pm="."><plain>Compared to patients with <z:mpath ids='MPATH_458'>normal</z:mpath> mitral valves, patients with bileaflet MVP (i) were over-represented by females (9/10 [90%] vs. 7/14 [50%], p=0.04), (ii) had a higher prevalence of biphasic/inverted T waves (7/9 [77.8%] vs. 4/14 [29%], p= 0.04), and (iii) on Holter interrogation had higher prevalence of ventricular bigeminy (9/9 [100%] vs. 1/10 [10%], p&lt;0.0001), <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (7/9 [78%] vs. 1/10 [10%], p= 0.006), and <z:hpo ids='HP_0006682'>premature ventricular contractions</z:hpo> (<z:mp ids='MP_0010018'>PVC</z:mp>) originating from outflow tract alternating with papillary muscle/fascicular region (7/9 [78%] vs. 2/10 [20%], p= 0.02) </plain></SENT>
<SENT sid="8" pm="."><plain>Over a median (range) 1.8 (0.1 - 11.9) years from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> placement, 13/24 (54%) have received appropriate <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>)-terminating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks </plain></SENT>
<SENT sid="9" pm="."><plain>Only bileaflet MVP was associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> recurrences requiring <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy on follow-up (logistic regression OR 7.2 with 95% CI from 1.1 - 48, p=0.028) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: We describe a 'malignant' subset of patients with MVP who experienced life threatening <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>This phenotype is characterized by bileaflet MVP, female sex, and frequent complex ventricular ectopy including <z:mp ids='MP_0010018'>PVC</z:mp> of outflow tract alternating with papillary muscle/fascicular origin </plain></SENT>
</text></document>